Work

A Phase 4 Open-Label Multicenter Study of Piflufolastat F 18 PET/CT or PET/MRI in Men with Newly Diagnosed Favorable Intermediate Risk Prostate Cancer: MIRROR

Year: 2024

Type: article

Study design: Study Protocol

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2024.07.1305

Authors: J.D. Tward, D. Josephson, C. Catana, M. Covington, A.S. Feldman, A. Purysko, I. Teslenko, J.C. Provost, H. An, R. Bilyk, B.S. Denes, G.A. Ulaner, P. Carroll

Institutions: University of Utah, Huntsman Cancer Institute, Tower Urology Medical Group, Massachusetts General Hospital, Harvard University, Cleveland Clinic, Lantheus Medical Imaging (United States), University of Southern California, University of California, San Francisco

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4402907237

FWCI:

Cites:

Cited by:

Related to: 10